TCL Archive Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR March 4, 1988
TCL Archive Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says February 20, 1998
TCL Archive Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients November 27, 2009
TCL Archive Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity October 28, 2011
TCL Archive In Brief: LYNNE PENBERTHY Was Named Associate Director For Surveillance Research In NCI’s Division of Cancer Control and Population Sciences November 8, 2013
